Client: Boehringer Ingelheim
Design & Animation: CS Daniel Lim
Production: David Hager
Cat Design: Jorge Fernandez del Castillo Gomez
Music & Sound Design: Arjen Jongeneel
Voice: Willemijn van Leeuwen

Year: 2014
Tags: animation, motion, graphics

Info:

Pharmaceutical company Boehringer Ingelheim works in human pharmaceuticals, animal health and biopharmaceuticals. One of their new products is Semintra, the first ever authorized angiotensin receptor blocker (ARBs) in veterinary medicine. It is a liquid form medicine, as instead of capsules, a new treatment option for cats diagnosed with chronic kidney disease.

With an eye to the identity and product, we were able to quickly come up with a voice-over script and generate simplistic styled design treatment and create an animation within a couple of days; using primitive shapes and lines to match Boehringer Ingelheim's new product.

'ARBs are vasodilators - they cause blood vessels to widen. This results in lowered blood pressure and reduced workload for the heart.'